Thursday, August 13, 2020

WuXi Global Forum 2014

2013 has been a great year in the world of pharma and biotech R&D. While we are still facing mounting productivity challenges, many have come to understand that no single company – no matter how committed to patients – can overcome these challenges on its...

WuXi Global 2017 Forum Recap

More than 1,500 industry leaders gathered at the WuXi Global Forum 2017. The annual event, held in San Francisco during the J.P. Morgan Healthcare Conference on Jan. 10, promotes new thinking on a global stage as we strive to find transformative models and solutions...

WuXi AppTec Unveils Manufacturing Center for Cutting Edge Cell and Gene Therapies

We are thrilled to announce the grand opening of our Center for Clinical and Commercial Manufacturing of Advanced Therapies in the Philadelphia Navy Yard. The 150,000 square foot biomanufacturing facility is designed for cell therapy products that utilize viral vectors such as chimeric antigen receptor...

WuXi Collaborates with University of Pennsylvania to Produce Gene Therapies

We are pleased to share with you that we have formed a strategic manufacturing collaboration with University of Pennsylvania’s Gene Therapy Program.  The collaboration will combine Penn’s significant expertise in viral vector production developed over 20 years with the manufacturing expertise and infrastructure of WuXi.  Scientists from Penn will...

WuXi NextCODE Raises $75 Million in Series B Financing to Accelerate Growth of Global Platform for Genomic Data

WuXi would like to congratulate WuXi NextCODE for raising $75 million in Series B financing, led by the company's current investors Temasek and Yunfeng Capital. WuXi NextCODE will focus the use of proceeds from this round on advancing the commercialization of its consumer solutions for the...

Subscribe to our Newsletter



Twitter LinkedIn